Whitepaper and App Notes

Blood Neurofilament Light Chain (NfL) Assay: Multiple Sclerosis


Publication Brief

Neurofilament light (NfL) is a cytoskeletal intermediate filament protein that is expressed in neurons and can be released in significant quantities following axonal damage or neuronal degeneration. NfL has been shown to be associated with multiple sclerosis (MS) and other neurodegenerative diseases. Download our flyer to learn more about the measurement of NfL with Simoa® and view recent publications demonstrating the value that ultrasensitive biomarker detection brings to MS research.